Cornerstone Therapeutics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Cornerstone Therapeutics ( CRTX) is a specialty pharmaceutical company focused on commercializing products for the hospital, respiratory and related specialty markets. This stock is trading up 4% to $6.85 in recent trading.

Today's Range: $6.53-$6.93

52-Week Range: $4.45-$8.64

Volume: 509,000

Three-Month Average Volume: 49,975

>>5 Biotech Stocks Under $10 Set to Soar

From a technical perspective, CRTX is ripping big to the upside here with monster volume, and the stock has entered breakout territory since shares have moved above near-term overhead resistance at $6.54. This move is now pushing CRTX within range of triggering another breakout trade. That trade will hit once CRTX takes out some overhead resistance levels at $6.96 to $7 with high volume.

Traders should now look for long-biased trades as long as CRTX is trending above $6.54, and once it clears $6.96 to $7 with heavy volume. Look for volume on that move that registers near or above 49,975 shares. At last check, CRTX has hit an intraday high of $6.93 and volume is well above its three-month average action of 49,975 shares. If that breakout triggers soon, then CRTX will have a chance of hitting $7.50 to $8.50 rather quickly.

If you liked this article you might like

Top Insider Trades: PSX YRCW CRTX IDIX

5 Biotech Stocks Under $10 Making Big Moves

4 Health Care Stocks Under $10 Close to Breakouts

Cornerstone Therapeutics Inc. Stock Upgraded (CRTX)

31 Drugs Facing FDA Approval in 2012-2013